No Data
No Data
MEME stocks are back strongly! GME surged nearly 180% in two days. Who will be next?
The agency believes that more retail traders will join this trend in the next few days, but the possibility of reaching the level of 2021 is still relatively low.
IGM Biosciences Inc (IGMS) Q1 2024 Earnings: Aligns With EPS Projections Amidst Clinical ...
Wedbush: Reiterates IGM Biosciences (IGMS.US) rating and adjusted from superior to superior market rating, with a target price of $20.00.
Wedbush: Reiterates IGM Biosciences (IGMS.US) rating and adjusted from superior to superior market rating, with a target price of $20.00.
Wedbush Reiterates Outperform on IGM Biosciences, Maintains $20 Price Target
Wedbush analyst Robert Driscoll reiterates IGM Biosciences (NASDAQ:IGMS) with a Outperform and maintains $20 price target.
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), IGM Biosciences (IGMS) and Elanco Animal Health (ELAN)
RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk
IGM Biosciences (IGMS) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $12 to $48.
No Data